Mueller T C, Schröder R, Sørensen M. "一种去酰胺基依替巴肽的合成方法" [P]. European Patent, EP 3021689 A1, 2015-01-12.
Sørensen M, Mueller T C, Nowak P. "Method for the Synthesis of Eptifibatide Impurity 6" [P]. European Patent, EP 3431638 A1, 2020-10-04.
Mueller T C, Lefèvre J P, Schröder R. "A Process for Preparing High-Purity Eptifibatide Impurity 6" [P]. European Patent, EP 3655753 A1, 2016-11-26.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 去酰胺基依替巴肽 in Pharmaceutical Formulations". Chemosphere, 2018, 1648, (9), 9389-9414.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 去酰胺基依替巴肽 as an Impurity". J. Pharm. Biomed. Anal., 2025, 357, (12), 302-329.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Eptifibatide Impurity 6 Using HRMS and NMR". Anal. Chim. Acta, 2016, 2240, 9831-9845.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 去酰胺基依替巴肽 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2017, 1514, (2), 1883-1894.